Patients with several painful functional gastrointestinal disorders (FGIDs) are reported to have a high prevalence of psychosocial disturbance. These aspects have not been studied extensively in patients with suspected Sphincter of Oddi dysfunction (SOD).
INTRODUCTION
Sphincter of Oddi dysfunction (SOD) encompasses a spectrum of disorders in which episodes of biliary / pancreatic-type pain are attributed to stenosis or spasm of the biliary and / or pancreatic sphincters. Th e diagnosis is most oft en considered in patients who have previously undergone cholecystectomy. About half of those will have some objective fi ndings on laboratory studies or imaging (e.g., abnormal liver enzymes or a dilated bile duct), and are categorized by the Milwaukee classifi cation as SOD types I and II ( 1, 2 ) . Patients who have similar symp-
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toms, but who have no signifi cant abnormalities demonstrated on standard imaging and laboratory tests, are categorized as suspected SOD III, with the supposition that episodes of pain are due to intermittent sphincter dysfunction. Th ese patients are very diffi cult to evaluate and to manage eff ectively, not least because there are no objective markers of the condition ( 3 ) .
Patients with burdensome pain are oft en referred to tertiary centers for evaluation and treatment. Th is usually involves endoscopic retrograde cholangio-pancreatography with Sphincter of Oddi manometry (SOM) ( 4 ) , which is used to decide whether to perform sphincter ablation by endoscopic sphincterotomy of the biliary and / or pancreatic sphincters. As the results of these treatments are suboptimal, and carry signifi cant hazards (e.g., occurrence of pancreatitis, bleeding, and perforation) ( 5 ) , it is important to ascertain whether additional factors, particularly psychosocial variables, co-occur and / or potentially modify pain symptoms in this patient population, and whether these factors aff ect treatment outcomes.
It is well recognized within the functional gastrointestinal disorder (FGID) population, in general, that patients with more severe and constant pain and psychosocial disturbance have poorer health status and treatment outcomes ( 6 ) . Specifi cally, psychosocial factors aff ect gastrointestinal (GI) sensorimotor function and / or symptoms in FGID as predisposing, precipitating, or perpetuating factors ( 7 ) . Numerous studies, examining FGID patient cohorts in various settings, mostly subspecialty clinics, reported high levels of comorbidity with psychiatric disorders, primarily mood and anxiety disorders, with most data obtained in patients diagnosed with irritable bowel syndrome (IBS) ( 6 -11 ) . Environmental stress in childhood and adulthood, specifi cally sexual and physical trauma, has been also linked with GI symptoms with high prevalence of abuse history among female patients in GI clinics and particularly in patients with IBS and other FGIDs ( 12 -16 ) . Sexual and / or physical abuse was reported in 40 -50 % of patients with IBS and other FGIDs seen in referral GI clinics ( 15 -16 ) . Predictive analyses showed that psychosocial and behavioral features have an important role in determining the severity of painful functional bowel disorders, and a history of abuse is associated with greater pain reporting, greater psychological distress, poorer health status, and outcome regardless of the GI diagnosis ( 16 ) . Maladaptive coping styles, such as " catastrophizing, " feelings of helplessness, or inability to control symptoms, have also been implicated in the association between psychopathology and severity and outcome of FGID symptoms ( 17 ) .
Surprisingly, despite these fi ndings in other FGIDs, there are few studies focusing on suspected SOD cohorts. One small trial of 11 patients with suspected SOD and 10 control subjects examined visceral hyperalgesia ( 18 ) . Although specifi cs were not provided, the authors noted that a sizeable minority of study patients scored in the 90th percentile for anxiety, depression, and somatization on the SCL-90-R inventory. Another study showed that both SOD patients and those with unexplained pancreatitis had high somatization scores, and abuse histories were common ( 19 ) . A recently published abstract by Moff att et al. ( 20 ) reported comparisons of psychometric profi les from a single center, measured by the SCL-90-R and the Whitely somatization index, between suspected SOD ( n = 18 type 2 and n = 54 type 3) and non-SOD ( n = 140) patients referred for endoscopic retrograde cholangiopancreatography. Th ey concluded that suspected SOD patients scored > 95th percentile for anxiety and depression levels as well as higher somatization and hostility than the non-SOD patients.
Because of the paucity of available prospective data, and to help shed light on the psychosocial underpinnings of this disabling condition, we undertook a prospective study of suspected type III SOD subjects in the EPISOD trial ( E valuating P redictors and I nterventions in S phincter of O ddi D ysfunction), an on-going, multicenter clinical trial designed to assess the effi cacy and safety of sphincterotomy in patients diagnosed clinically with suspected SOD. Th e trial is funded by a grant from the National Institute of Diabetes, Digestion and Kidney Diseases (NCT00688662). Th is paper analyzes the baseline characteristics of the EPISOD study population and assesses the prevalence of psychopathology and the relationship with baseline pain indices.
METHODS

Patients
Th e EPISOD study protocol has been reported in detail ( 21 ) . It is a randomized, double-blind, sham-controlled trial conducted in patients with clinical characteristics suggestive of SOD. Patients referred to seven tertiary centers in the United States were initially " prescreened " to identify a cohort with the following characteristics: aged 18 -65, signifi cant pain-related disability aft er cholecystectomy, no pancreatic pathology or prior sphincter treatment, not taking narcotics daily, and apparently suitable for entry into a clinical trial. Aft er consent, further criteria and questionnaires were applied. Pain characteristics had to be consistent with biliary SOD as defi ned by the ROME III criteria ( 4 ), modifi ed to include patients with daily abdominal discomfort in addition to episodes of pain. Disability due to pain was measured by the recurrent abdominal pain intensity and disability (RAPID) instrument that was developed and validated specifi cally for this study, as other pain measures seemed inadequate to measure the burden of intermittent pains ( 22 ) . It asks patients to report how much the three domains of work, house duties, and leisure were aff ected in the prior 90 days, with a maximum score of 270. For inclusion, patients had to report more than 11 days of disability due to pain (RAPID grade 3 or 4). Laboratory tests within 1 week and within 6 months of the baseline visit could not be more than two times the upper limit of normal for direct bilirubin, alkaline phosphatase, amylase, and lipase, and no more than three times the upper limit of normal for transaminases.
Patients receiving antidepressants for pain control must have been taking them for a minimum of 1 month before the baseline assessment, and patients with known depressive and / or anxiety disorders receiving psychopharmacological treatment must have been on a stable dose for at least 6 weeks. Baseline measures included the Mini International Neuropsychiatric Interview to assess pres- ( 27 ) and health-related quality of life as measured by the SF -36 ( 28 ) . Patients were excluded if they had major psychiatric disorders (psychotic and bipolar disorders), current substance abuse, eating disorders, current severe depression (as defi ned by a BDI-II score of 22 or higher), or suicidal risk (assessed by BDI-II and Mini International Neuropsychiatric Interview questionnaires).
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Study intervention
Eligible consenting subjects underwent endoscopic retrograde cholangio-pancreatography with pancreatic and biliary sphincter manometry. Subjects with successful pancreatic manometry, and without duct abnormalities such as pancreas divisum, were randomized using a 2:1 allocation to sphincterotomy or sham. Th ose allocated to the sphincterotomy group who had elevated sphincter pressures were randomized a second time using a 1:1 ratio to either biliary or dual sphincterotomy. All subjects received a small (3 -5 French guage diameter ) temporary pancreatic stent to reduce the risk of post-procedure pancreatitis; none were given prophylactic anti-infl ammatory medications. Subjects were observed in hospital overnight and returned to their referring physicians for standard clinical follow-up. Research coordinators at each site called the subjects at 1 week post procedure and monthly for 12 months. In addition, calls were made at 9 and 12 months by research staff at the central coordinating center to collect the primary outcome. Th e subjects, referring physicians and the callers were all blinded to the treatment allocation. Subjects dissatisfi ed with their progress were off ered reassessment at the study site by an independent physician unaware of the treatment allocation.
Success was defi ned as patients having < 6 days of disability due to abdominal pain as measured using the RAPID instrument at months 9 and 12 post procedure, with no re-intervention during the follow-up period and no use of prescription analgesics for abdominal pain during months 10, 11, and 12.
Secondary outcomes included manometry results and their association with the primary outcome, success rates of subjects receiving biliary sphincterotomy as compared with dual sphincterotomy, the eff ect of prespecifi ed potential prognostic factors, quality of life, and resource utilization.
Local institutional review board approval was obtained at all participating sites and written informed consent was obtained from the patients before study enrollment.
Patients who were otherwise eligible but who declined randomization were invited to participate in an observational study (EPISOD 2) in which sphincterotomy was performed based on the results of manometry.
Statistical analysis
SAS soft ware version 9 (SAS Institute, Cary, NC) was utilized to perform statistical analyses. Baseline variables were described using counts and percentages for categorical data or means and s.d. (medians and interquartile ranges) for continuous normal (skewed) data. Associations between disability and psychosocial measures as well as pain intensity and psychosocial measures were assessed using Pearson ' s and Spearman ' s correlations and multivariable linear and quantile regression. Quantile regression, similar to ordinary least squares regression, however, oft en utilized for non-normally distributed data, models the relationship between covariates and the conditional quantiles of the outcome variable ( 29 ) . All tests were conducted using a two-sided significance level of < 0.05.
RESULTS
A total of 1,460 patients were prescreened for eligibility. Of these, 1,172 failed for a variety of reasons, the most common being " daily use of prescription analgesics " ( n = 200), " liver function tests outside the allowable range " ( n = 191), and " pain not severe enough to justify endoscopic retrograde cholangio-pancreatography " ( n = 156). Twenty-nine (2.5 % ) patients were not considered further because of presence of obvious signifi cant psychiatric disorders. Two hundred and eighty-eight patients consented to the study. Twenty-eight (10 % ) of those were excluded for protocol-specifi c psychological exclusionary criteria. A total of 214 patients were randomized between July 2008 and March 2012. Seventy-two patients were enrolled into EPI-SOD 2, the naturalistic follow-up study.
Th e overall mean age of the EPISOD participants was 38 years. Most were females (92 % ), non-Hispanic (92.5 % ), and fully or part-time employed (73 % ). Cholecystectomy had been performed on average 4 years before study enrollment. At cholecystectomy, 47 % were known to have gallstones; the remainder were shown or assumed to have had a functional gallbladder problem. Symptoms characteristic of IBS (as defi ned by Rome III) were present in 34 % . Th e median RAPID disability score in the 90 days before randomization was 74 (range: 11 -270) and the average intensity of pain episodes (on a 10-point scale) was 7 (s.d. = 1.88). Fift y-fi ve (26 % ) patients were taking narcotic analgesics for abdominal pain on an average of 33 days in the 3 months before enrollment. Table 1 presents pain-related and psychosocial assessment data and their breakdown by quartiles of the RAPID scores. Eightyfour (39 % ) patients received antidepressants and / or anxiolytics. Nine percent of the patients met criteria for an anxiety disorder (panic disorder and / or agoraphobia at 2.3 % and generalized anxiety disorder at 6.5 % ) at baseline and 8 % had current depression (major depressive episode or dysthymia). Baseline median anxiety and depression scores were BDI-II of 7 (scale total score range: 0 -26), HADS-D of 3 (scale total score range: 0 -16) and HADS-A of 4 (total score range: 0 -16). Median Coping Skills QuestionnaireCatastrophizing Subscale score was 6 (total score range: 0 -32). Eighteen percent of patients reported past sexual trauma including inappropriate touching: < 13 years of age: 13 % touching; 3 % rape; 13 + years of age: 6 % touching; 4 % rape; 10 % reported physical abuse. Th e mean physical and mental composite scores on the medical outcomes study short-form 36 (SF-36) were 2 s.d. below Although frequency of pain episodes, SF-36 pain domain score, and use of antidepressants each worsen with increasing quartiles of the disability score, other measures such as pain intensity and daily abdominal discomfort did not show this pattern with disability score ( Table 1 ). Th ere was poor correlation between psychosocial measures and baseline pain-related disability for all psychosocial measures ( r < 0.50). It is noteworthy that patients with higher RAPID scores had worse SF-36 mental composite scores and were more depressed, but they were not more anxious ( Figure 1 ). Further, subjects with current diagnosis of depression or dysthymia as assessed by the Mini International Neuropsychiatric Interview had signifi cantly higher median RAPID scores than those without the diagnosis ( Figure 1 : 120 days vs. 70 days; P = 0.005). Table 2 illustrates the psychosocial and pain disability data in EPISOD patients with and without concomitant symptoms of IBS (by Rome III criteria), and the patients in EPISOD 2. Th ere were signifi cant higher depression scores in IBS patients when measured by BDI, but not HADS-D. Th ere was no diff erence in psychosocial data in subjects with and without daily abdominal discomfort, and those with and without gallstones at cholecystectomy. Th ere were no signifi cant diff erences between the randomized patients (EPI-SOD) and those treated by standard of care (EPISOD 2).
DISCUSSION
Th is is the largest reported data set of demographic, clinical, and psychosocial characteristics of patients with suspected SOD, with rigorous prospective collection. Th e important and surprising overall fi nding was the relatively low level of depression and anxiety despite high levels of disability due to pain. In fact, comparisons with age-and gender-adjusted US population norms indicated no statistically signifi cant diff erence on SF-36 mental functioning 
PANCREAS AND BILIARY TRACT
Brawman-Mintzer et al.
Mini International Neuropsychiatric Interview for Diagnostic and
Statistical Manual of Mental Disorders-IV psychiatric disorders, a recent trial of 268 IBS subjects by Th ijssen et al. ( 9 ) reported that 30 and 22 % of IBS subjects met HADS cutoff criteria for anxiety and depression, respectively, again indicating higher levels of mood and anxiety disturbance in IBS population. As stated earlier, history of traumatization has been oft en associated with FGIDs, with numerous studies indicating high ( P = 0.52), although physical functioning score was signifi cantly worse than the population norm ( P < 0.0001). Eight percent of EPISOD patients met criteria for current depressive disorder and 9 % had a diagnosis of an anxiety disorder. Th ese rates of anxiety and depressive disorders are lower than those reported in the many studies of patients with FGIDs, and even those derived from the general population. For example, in a landmark epidemiological study evaluating lifetime and current (12 month) prevalence of psychiatric disorders in an adult US population ( n = 8,089), Kessler et al. ( 30 ) found that ~ 13 % of female responders had a current diagnosis of major depression and over 22 % had an anxiety disorder. Th ese prevalence rates are, by and large, consistent across other epidemiological studies ( 31 ) . Similarly, severity of mood and anxiety symptoms in the EPISOD patients, as measured by HADS and BDI-II scales, was surprisingly comparable to those reported in normal populations (with population norm reports for mean HADS-A and HADS D scores of 5 and 4, respectively, and BDI-II score of 14 among female subjects) ( 32, 33 ) .
Th e extensive literature on other FGIDs have demonstrated prevalence rates of 50 % and higher for mood and anxiety disorders in subjects seen in clinical settings with IBS and other FGIDs ( 6 -11 ) . It should be noted that published studies vary greatly in their methodology and diagnostic assessment instruments; some utilized validated diagnostic instruments that employ strict diagnostic criteria, whereas others used self-report questionnaires, potentially explaining diff erences in results. Th erefore, to help further understand the EPISOD population, we examined scores on patient-rated HADS-A and HADS-D using cutoff scores of ≤ 8, which is found to have the optimal sensitivity and specifi city for potential " caseness " for depression and anxiety disorders ( 24, 34 ) . Twelve and 17 % of EPISOD patients met the above cutoff criteria on HADS-D and HADS-A, respectively. Although these rates are higher than depression and anxiety disorders rates based on the 80.00 (11 -270) 64.00 (12 -270) 49.50 (11 -260) BDI-II, Beck depression inventory-II; CSQ-CAT, Coping Skills QuestionnaireCatastrophizing Subscale ; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders-IV; EPISOD, Evaluating Predictors and Interventions in Sphincter of Oddi Dysfunction; HADS, Hospital Anxiety and Depression Scale; IBS, irritable bowel syndrome; RAPID, recurrent abdominal pain intensity and disability; SF-36, medical outcomes study short-form 36.
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Psychosocial Characteristics of Patients With SOD prevalence rates of sexual and physical trauma in these patients. In a population survey ( 12 ) of 919 responders, Talley et al. ( 13 ) reported a signifi cant association between IBS and history of abuse. In a later study of GI outpatients, Talley et al. ( 13 ) found that 22 % of those with physician-based diagnosis of FGID had some form of abuse vs. 16 % of those with structural disease. A study of an Italian sample of GI outpatients reported that 32 % of those with FGIDs had experienced sexual or physical abuse ( 14 ) . Irwin et al. ( 15 ) reported 44 % of abuse in 50 consecutive patients with IBS. Similarly, Drossman et al. ( 16 ) also reported 44 % sexual or physical abuse history in 206 GI clinic subjects. FGID patients were more likely than those with structural diagnoses to report rape or frequent physical abuse ( 16 ) . In contrast, 24 % of EPISOD patients reported a history of sexual or physical abuse, with 18 % reporting some type of sexual abuse and 10 % physical abuse. Th ese study results should be viewed in the context of the comparably high rates of abuse reported in representative samples of women in the United States ( 35 -37 ) .
Surprisingly, the presence of comorbid IBS did not have a significant eff ect on any of the psychosocial variables in EPISOD patients except somewhat higher endorsement of depressive symptoms and catastrophizing in the comorbid group, although these scores are lower than those observed by Drossman, in a sample of 431 welldefi ned IBS subjects with mean BDI-II score of 10.47 and Coping Skills Questionnaire-Catastrophizing Subscale of 10.02 in that cohort (D. Drossman, personal communication). Also, we found no diff erence in the measured characteristics of patients who had their cholecystectomies for organic pathology (gallstones) when compared with those done for demonstrated or assumed functional gall bladder disease.
Overall, the correlation between psychosocial measures and baseline pain intensity and pain disability was low for all psychosocial measures. However, we found that patients with more painrelated disability, as measured by RAPID scores, were signifi cantly more depressed. Th is pattern was not seen when assessing anxiety.
It could be argued that patients with suspected SOD may differ from those with chronic functional GI disorders because of the episodic nature of their pain. Patients with intermittent pain presumably have pain that is most related to peripheral aff erent excitation compared with patients with chronic functional GI disorders, or chronic pain in general, who have greater contributions of central sensitization and central nervous system disinhibition of pain regulatory pathways. Th e latter is strongly associated with high psychosocial disturbance ( 38, 39 ) . However, half of EPISOD patients did have some daily abdominal discomfort, and their levels of psychosocial disturbance were no diff erent from the rest.
One may question whether these surprising results are generalizable, or only because of selection bias. It could be argued that patients who obtain referral to tertiary centers and agree to participate in a randomized, sham-controlled trial might not be representative of the whole SOD population. However, the baseline psychosocial characteristics of the 72 patients concurrently enrolled in the EPISOD 2 observational study were no diff erent. An important argument against the idea that the data suff er from selection bias is that research studies in patients with IBS suggest that those who seek treatment are actually the more psychologically disturbed ( 11 ) . As in many trials, site investigators were allowed to exclude potential patients at prescreening if they appeared to be unsuitable for a clinical trial, for any reason, including psychological disturbance. However, that reason for exclusion was noted in only 2.5 % of the total patients prescreened. Competitive enrollment into a sham-controlled trial rendered overuse of this exclusion unlikely. Aft er consent, a further 28 patients were excluded for more defi ned and severe psychological problems. Two hundred potential subjects were excluded because they were taking daily narcotics (making assessment of treatment outcomes diffi cult) but only eight of these also failed study psychological entry criteria.
Th e EPISOD baseline data show that the psychosocial disability in patients with severe symptoms from suspected SOD may not be diff erent than the general population, keeping in mind that the known rates of psychological issues and trauma history in age-and gender-matched populations are high. Th is may have signifi cant implications for clinical practice, and we look forward to seeing how psychological comorbidity infl uences the clinical response to sphincterotomy or sham treatment in this population.
Study Highlights
WHAT IS CURRENT KNOWLEDGE
3 Sphincter of Oddi dysfunction (SOD) is currently considered to be one of the functional gastrointestinal disorders (FGIDs).
3 Patients with FGIDs are believed to have signifi cant psycho logical problems, including history of trauma. These aspects have not been studied extensively in patients with suspected SOD.
WHAT IS NEW HERE
3 We report the demographics, pain burden, clinical, and psychological characteristics of a large cohort of patients with suspected SOD entering a randomized sham-controlled treatment study.
3 The main fi nding is that these patients appear to be less psychologically distressed than reported from other FGID cohorts, indeed consistent with data from random population surveys.
